Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kubilay Karaboyun

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Asia-Pacific Journal of Clinical Oncology|June 5, 2024
Comprehensive analysis of the prognostic role of laboratory indices in advanced lung cancer patientsEyyüp Cavdar, Kubilay Karaboyun, Kaan Kara
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|May 16, 2023
A New Mortality Prediction Model in Advanced Stage Cancer Patients Requiring Hospitalisation while Receiving Active Systemic TherapyKubilay Karaboyun, Yakup Iriagac, Eyyup Cavdar, et al.
Journal of Geriatric Oncology|April 1, 2022
Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancerEyyup Cavdar, Yakup Iriagac, Kubilay Karaboyun, et al.
Journal of Cancer Research and Therapeutics|March 30, 2024
Comparison of three equations for estimating glomerular filtration rate as predictors of cisplatin-related acute kidney injury in lung cancer patients with normal renal functionKubilay Karaboyun, Yakup İriağaç, Eyyüp Çavdar, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 30, 2022
The influence of visual objects and music on anxiety levels of breast cancer patients scheduled to experience chemotherapy for the first time: a prospective randomized clinical studyYakup İriağaç, Eyyüp Çavdar, Kubilay Karaboyun, et al.
Medicine|October 1, 2025
The role of peripheral T lymphocyte subsets and PD-1 expression as a biomarker for neoadjuvant treatment response in breast cancerTarkan Yetişyiğit, Kubilay Karaboyun, Yakup İriağaç, et al.
Revista Da Associacao Medica Brasileira (1992)|October 22, 2025
Expression of gamma-aminobutyric acid type A receptor subunit π and minichromosome maintenance-3 in breast cancer patients treated with neoadjuvant chemotherapy: a target molecule or a proliferation marker?Yakup İriagac, Meltem Oznur, Eyyup Çavdar, et al.
Revista Da Associacao Medica Brasileira (1992)|March 15, 2023
A logarithmic model for hormone receptor-positive and breast cancer patients treated with neoadjuvant chemotherapyErdoğan Selçuk Şeber, Yakup İriagac, Eyyup Çavdar, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 10, 2023
Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy?Kubilay Karaboyun, Eyyup Cavdar, Yakup Irıagac, et al.
Neoplasma|April 26, 2022
The diagnostic contribution of magnetic resonance imaging in the detection of axillary metastasis after neoadjuvant chemotherapyYakup İriağaç, Kubilay Karaboyun, Eyyüp Çavdar, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Asia-Pacific Journal of Clinical Oncology|June 5, 2024
Comprehensive analysis of the prognostic role of laboratory indices in advanced lung cancer patientsEyyüp Cavdar, Kubilay Karaboyun, Kaan Kara
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|May 16, 2023
A New Mortality Prediction Model in Advanced Stage Cancer Patients Requiring Hospitalisation while Receiving Active Systemic TherapyKubilay Karaboyun, Yakup Iriagac, Eyyup Cavdar, et al.
Journal of Geriatric Oncology|April 1, 2022
Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancerEyyup Cavdar, Yakup Iriagac, Kubilay Karaboyun, et al.
Journal of Cancer Research and Therapeutics|March 30, 2024
Comparison of three equations for estimating glomerular filtration rate as predictors of cisplatin-related acute kidney injury in lung cancer patients with normal renal functionKubilay Karaboyun, Yakup İriağaç, Eyyüp Çavdar, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 30, 2022
The influence of visual objects and music on anxiety levels of breast cancer patients scheduled to experience chemotherapy for the first time: a prospective randomized clinical studyYakup İriağaç, Eyyüp Çavdar, Kubilay Karaboyun, et al.
Medicine|October 1, 2025
The role of peripheral T lymphocyte subsets and PD-1 expression as a biomarker for neoadjuvant treatment response in breast cancerTarkan Yetişyiğit, Kubilay Karaboyun, Yakup İriağaç, et al.
Revista Da Associacao Medica Brasileira (1992)|October 22, 2025
Expression of gamma-aminobutyric acid type A receptor subunit π and minichromosome maintenance-3 in breast cancer patients treated with neoadjuvant chemotherapy: a target molecule or a proliferation marker?Yakup İriagac, Meltem Oznur, Eyyup Çavdar, et al.
Revista Da Associacao Medica Brasileira (1992)|March 15, 2023
A logarithmic model for hormone receptor-positive and breast cancer patients treated with neoadjuvant chemotherapyErdoğan Selçuk Şeber, Yakup İriagac, Eyyup Çavdar, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 10, 2023
Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy?Kubilay Karaboyun, Eyyup Cavdar, Yakup Irıagac, et al.
Neoplasma|April 26, 2022
The diagnostic contribution of magnetic resonance imaging in the detection of axillary metastasis after neoadjuvant chemotherapyYakup İriağaç, Kubilay Karaboyun, Eyyüp Çavdar, et al.
Pageof 2